• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2009年甲型H1N1流感病毒的血清流行率——我们目前的情况如何?

Seroprevalence to influenza A(H1N1) 2009 virus--where are we?

作者信息

Broberg Eeva, Nicoll Angus, Amato-Gauci Andrew

机构信息

Surveillance and Response Support, European Centre for Disease Prevention and Control (ECDC), Tomtebodavägen 11A, SE-171 83 Stockholm, Sweden.

出版信息

Clin Vaccine Immunol. 2011 Aug;18(8):1205-12. doi: 10.1128/CVI.05072-11. Epub 2011 Jun 8.

DOI:10.1128/CVI.05072-11
PMID:21653743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3147351/
Abstract

Age-specific seroprevalences for influenza virus make important contributions to estimating the burden of infection and determining the vulnerable populations. It is especially difficult to know the true clinical attack rates of the 2009 influenza A(H1N1) pandemic; however, we can estimate infection rates through analyses of seroprevalences based on national studies from different continents and countries with different demographics. After the 2009 influenza A(H1N1) pandemic, seroprevalence studies found 5 to 60% of populations across different continents and age groups having antibodies against the A(H1N1) 2009 virus. The seropositivity was highest in children and teenagers (20 to 60%) as well as in the elderly older than 80 years (20 to 40%). Preexisting cross-reactive antibodies against the virus were present mostly in sera of older people (born before 1950) who could have encountered viruses descended from the 1918 pandemic viruses. Experience with the 2009 pandemic indicates how essential early and timely serology data against the emerging virus can be for informing decisions on use of antivirals and vaccination campaigns, especially in regard to risk groups. The objectives of this review were to summarize the current data available on seroprevalence before and after the 2009 influenza A(H1N1) pandemic and the lessons learned for future pandemic preparedness.

摘要

流感病毒的年龄特异性血清流行率对于估计感染负担和确定易感人群具有重要意义。要了解2009年甲型H1N1流感大流行的真实临床发病率尤其困难;然而,我们可以通过分析来自不同大陆和具有不同人口统计学特征的国家的全国性研究中的血清流行率来估计感染率。2009年甲型H1N1流感大流行之后,血清流行率研究发现,不同大陆和年龄组中5%至60%的人口具有针对2009年甲型H1N1病毒的抗体。血清阳性率在儿童和青少年中最高(20%至60%),在80岁以上的老年人中也较高(20%至40%)。针对该病毒的预先存在的交叉反应抗体大多存在于出生于1950年之前的老年人血清中,这些人可能接触过源自1918年大流行病毒的毒株。2009年大流行的经验表明,针对新出现病毒的早期和及时血清学数据对于为抗病毒药物使用和疫苗接种运动的决策提供信息至关重要,特别是对于风险群体。本综述的目的是总结2009年甲型H1N1流感大流行前后现有的血清流行率数据以及为未来大流行防范所吸取的教训。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe4/3147351/0aa82963c2f3/zcd9990941770003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe4/3147351/b7ff98905909/zcd9990941770001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe4/3147351/b49439817874/zcd9990941770002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe4/3147351/0aa82963c2f3/zcd9990941770003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe4/3147351/b7ff98905909/zcd9990941770001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe4/3147351/b49439817874/zcd9990941770002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe4/3147351/0aa82963c2f3/zcd9990941770003.jpg

相似文献

1
Seroprevalence to influenza A(H1N1) 2009 virus--where are we?2009年甲型H1N1流感病毒的血清流行率——我们目前的情况如何?
Clin Vaccine Immunol. 2011 Aug;18(8):1205-12. doi: 10.1128/CVI.05072-11. Epub 2011 Jun 8.
2
Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.估算 2009 年流感大流行的年龄别累积发病率:来自 19 个国家的 A(H1N1)pdm09 血清学研究的荟萃分析。
Influenza Other Respir Viruses. 2013 Sep;7(5):872-86. doi: 10.1111/irv.12074. Epub 2013 Jan 21.
3
Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.奥地利成年人中 2009 年大流行性流感 A(H1N1)病毒抗体的流行前和流行后情况。
J Med Virol. 2012 Sep;84(9):1331-4. doi: 10.1002/jmv.23337.
4
Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.2009 年甲型 H1N1 流感大流行在法国大都市人群中的血清学研究。
Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2.
5
Post-pandemic seroprevalence of 2009 pandemic influenza A (H1N1) virus in Shandong Province, China.中国山东省 2009 年甲型 H1N1 流感大流行后的血清流行率。
Jpn J Infect Dis. 2012;65(5):410-4. doi: 10.7883/yoken.65.410.
6
Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.2009 年土耳其甲型 H1N1 流感大流行第一波后的血清流行率。
Jpn J Infect Dis. 2012;65(1):13-8.
7
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.评估新型甲型 H1N1 流感病毒在不同年龄段的基线抗体流行率和感染发病率。
Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.
8
Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.在 2009 年大流行的第一波期间感染甲型 H1N1pdm09:来自孟加拉国达卡的纵向血清流行病学研究的证据。
Influenza Other Respir Viruses. 2017 Sep;11(5):394-398. doi: 10.1111/irv.12462. Epub 2017 Jul 26.
9
Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.2009-2010 年希腊流感大流行 H1N1 后的血清流行病学研究。
Vaccine. 2011 Sep 2;29(38):6664-9. doi: 10.1016/j.vaccine.2011.06.098. Epub 2011 Jul 14.
10
Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.接种 2009 年南半球季节性三价流感疫苗前后儿童(6 个月至 9 岁)对甲型流感(H1N1)2009 无交叉反应抗体:一项前瞻性研究。
Influenza Other Respir Viruses. 2011 Jan;5(1):7-11. doi: 10.1111/j.1750-2659.2010.00172.x. Epub 2010 Aug 24.

引用本文的文献

1
Mathematical modelling for vaccine efficacy trials during the future epidemics of emerging respiratory infections.新发呼吸道感染未来流行期间疫苗效力试验的数学建模
Hum Vaccin Immunother. 2025 Dec;21(1):2467554. doi: 10.1080/21645515.2025.2467554. Epub 2025 Feb 19.
2
Neuraminidase Antibody Response to Homologous and Drifted Influenza A Viruses After Immunization with Seasonal Influenza Vaccines.季节性流感疫苗免疫后对同源和变异甲型流感病毒的神经氨酸酶抗体反应
Vaccines (Basel). 2024 Nov 27;12(12):1334. doi: 10.3390/vaccines12121334.
3
Influenza Vaccine Effectiveness Among Children: 2011-2020.

本文引用的文献

1
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.评估新型甲型 H1N1 流感病毒在不同年龄段的基线抗体流行率和感染发病率。
Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.
2
Serologic status for pandemic (H1N1) 2009 virus, Taiwan.台湾地区 2009 年甲型 H1N1 流感病毒血清学流行状况。
Emerg Infect Dis. 2011 Jan;17(1):76-8. doi: 10.3201/eid1701.100014.
3
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.严重大流行 2009 年 H1N1 流感疾病是由致病免疫复合物引起的。
儿童流感疫苗有效性:2011-2020 年。
Pediatrics. 2023 Apr 1;151(4). doi: 10.1542/peds.2022-059922.
4
Human Immunity and Susceptibility to Influenza A(H3) Viruses of Avian, Equine, and Swine Origin.人类对源自禽、马和猪的甲型(H3)流感病毒的免疫力和易感性。
Emerg Infect Dis. 2023 Jan;29(1):98-109. doi: 10.3201/eid2901.220943.
5
Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic Risk.评估流感大流行风险的一部分是确定现有人群的免疫情况。
Emerg Infect Dis. 2022 May;28(5):977-985. doi: 10.3201/eid2805.211965.
6
Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay.高通量多重流感抗体检测分析在人类中流感疫苗接种和自然感染后的抗体全景分析。
mBio. 2021 Feb 2;12(1):e02808-20. doi: 10.1128/mBio.02808-20.
7
Landscape of coordinated immune responses to H1N1 challenge in humans.人类对 H1N1 挑战的协调免疫反应景观。
J Clin Invest. 2020 Nov 2;130(11):5800-5816. doi: 10.1172/JCI137265.
8
Detection of H1 Swine Influenza A Virus Antibodies in Human Serum Samples by Age Group.按年龄组检测人血清样本中的 H1 猪流感 A 病毒抗体。
Emerg Infect Dis. 2020 Sep;26(9):2118-2128. doi: 10.3201/eid2609.191796.
9
Identification of novel influenza A virus exposures by an improved high-throughput multiplex MAGPIX platform and serum adsorption.通过改进的高通量多重 MAGPIX 平台和血清吸附来鉴定新型流感病毒暴露。
Influenza Other Respir Viruses. 2020 Mar;14(2):129-141. doi: 10.1111/irv.12695. Epub 2019 Nov 8.
10
Seroprevalence of influenza A H1N1 (swine) infection in the human population in a cantonment.某营地人群中甲型H1N1(猪源)流感感染的血清流行率。
Med J Armed Forces India. 2019 Jul;75(3):312-317. doi: 10.1016/j.mjafi.2018.08.003. Epub 2019 Jun 4.
Nat Med. 2011 Feb;17(2):195-9. doi: 10.1038/nm.2262. Epub 2010 Dec 5.
4
Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison--a serological survey.芬兰驻军爆发 2009 年甲型 H1N1 流感大流行——血清学调查。
Euro Surveill. 2010 Nov 11;15(45):19709.
5
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic.2009 年甲型 H1N1 流感大流行后具有代表性的全国人群中的风险因素和免疫情况。
PLoS One. 2010 Oct 14;5(10):e13211. doi: 10.1371/journal.pone.0013211.
6
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.2009 年甲型 H1N1 流感在香港的感染发病率和严重程度。
Clin Infect Dis. 2010 Nov 15;51(10):1184-91. doi: 10.1086/656740.
7
Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.2009 年澳大利亚献血者中 2009 年甲型 H1N1 流感病毒的血清流行率。2009 年 10 月至 12 月。
Euro Surveill. 2010 Oct 7;15(40):19678. doi: 10.2807/ese.15.40.19678-en.
8
Moderate pandemic, not many dead--learning the right lessons in Europe from the 2009 pandemic.适度大流行,死亡人数不多——欧洲从2009年大流行中汲取正确教训
Eur J Public Health. 2010 Oct;20(5):486-8. doi: 10.1093/eurpub/ckq114.
9
Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.2009 南半球冬季第一次大流行后,澳大利亚新南威尔士州居民中的甲型 H1N1 2009 流感抗体。
PLoS One. 2010 Sep 7;5(9):e12562. doi: 10.1371/journal.pone.0012562.
10
High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009.2009 年秋季大流行和大规模疫苗接种运动后,挪威人群中抗 2009 年大流行性流感 A(H1N1)病毒的抗体高流行率。
Euro Surveill. 2010 Aug 5;15(31):19633.